Holen Sie sich die Stockscreener-App
75.22
1.88%
1.39
Vorhandelsmarkt:
75.22
Schlusskurs vom Vortag:
$73.83
Offen:
$73.51
24-Stunden-Volumen:
1.34M
Relative Volume:
1.17
Marktkapitalisierung:
$13.04B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
34.82
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
+13.49%
1M Leistung:
+6.12%
6M Leistung:
+2.31%
1J Leistung:
+7.40%
1-Tages-Spanne:
$73.05
$75.98
1-Wochen-Bereich:
$66.80
$75.98
52-Wochen-Spanne:
$60.70
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
75.22 | 12.81B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
565.51 | 202.93B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.07B | 21.84B | 1.68B | 2.55B | 5.8322 |
|
ALC
Alcon Inc
|
78.61 | 39.02B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
252.11 | 36.91B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
266.66 | 19.70B | 2.96B | 487.70M | 344.00M | 6.6758 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Can Solventum Corporation stock resist broad market declines2025 Performance Recap & High Conviction Investment Ideas - newser.com
Is Solventum Corporation stock attractive for growth fundsWeekly Volume Report & Smart Money Movement Alerts - newser.com
Is Solventum Corporation stock inflation resilientJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Why Solventum Corporation stock stays on top picksJuly 2025 Sentiment & Weekly Breakout Stock Alerts - newser.com
How to escape a deep drawdown in Solventum CorporationPortfolio Update Report & Reliable Price Breakout Alerts - newser.com
Solventum Stock: Analyst Estimates & Ratings - Barchart.com
A Look at Solventum's Valuation Following Upbeat Q3 Earnings and Raised 2025 Outlook - simplywall.st
5 Must-Read Analyst Questions From Solventum’s Q3 Earnings Call - FinancialContent
Transcript : Solventum Corporation Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11 - MarketScreener
Solventum (SOLV) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
Is Solventum a Bargain After Recent Innovation and Partnerships Drive 9% Price Jump? - Yahoo Finance
Why Solventum Corporation stock stays resilientInsider Buying & Real-Time Volume Analysis Alerts - newser.com
Certain Common Stock of Solventum Corporation are subject to a Lock-Up Agreement Ending on 12-NOV-2025. - MarketScreener
Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance (NYSE:SOLV) - Seeking Alpha
UBS Maintains Solventum (SOLV) Neutral Recommendation - Nasdaq
SOLV: UBS Raises Price Target Amid Neutral Rating Stance | SOLV Stock News - GuruFocus
UBS Adjusts Price Target on Solventum to $79 From $77, Maintains Neutral Rating - MarketScreener
Cautious Outlook on Solventum Corporation Amid Cost-Saving Initiatives and Tariff Concerns - TipRanks
Can Solventum Corporation stock rebound after recent weaknessMarket Volume Summary & Fast Moving Trade Plans - newser.com
Solventum Lifts Outlook After Topping Earnings Expectations - Finimize
Solventum’s Earnings Call Highlights Growth and Optimism - The Globe and Mail
Solventum : Earnings Webcast Q3 2025 - MarketScreener
SOLV Gains on Q3 Earnings & Sales Beat, Raises '25 EPS Outlook - sharewise.com
Solventum Corp. stock rises Friday, outperforms market - MSN
Solventum price target raised to $98 from $94 at Piper Sandler - TipRanks
Solventum (SOLV) Q3 2025 Earnings Call Transcript - The Globe and Mail
Balanced Outlook on Solventum Corporation: Growth Potential Amidst Tariff Challenges and Strategic Initiatives - TipRanks
Wells Fargo Adjusts Solventum Price Target to $72 From $82, Maintains Equal Weight Rating - MarketScreener
Solventum outlines $500M annual savings target through new restructuring while advancing toward 4%-5% long-range growth - MSN
Solventum Corporation: Strong Q3 Results Overshadowed by Growth Concerns and Transformation Costs - TipRanks
Solventum Q3 2025 Earnings Beat Estimates, Raises Full-Year GuidanceNews and Statistics - IndexBox
Solventum (SOLV) Q3 2025 Earnings Call Transcript - The Motley Fool
Solventum up after raising annual profit forecast - TradingView
Solventum Corporation Shares Surge Amid Strong Q3 Results - TipRanks
Piper Sandler Maintains Solventum (SOLV) Overweight Recommendation - Nasdaq
Jefferies Adjusts Price Target on Solventum to $75 From $80, Maintains Hold Rating - MarketScreener
Piper Sandler Adjusts Price Target on Solventum to $98 From $94, Maintains Overweight Rating - MarketScreener
Solventum Lifts Profit Outlook After Strong Quarter - Finimize
How Solventum’s (SOLV) Surging Q3 Earnings and Raised Guidance Will Impact Investors - simplywall.st
Solventum: Q3 Earnings Snapshot - theheraldreview.com
Solventum Corp (SOLV) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Debt ... By GuruFocus - Investing.com Canada
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):